Esta web utiliza cookies para que podamos ofrecerte la mejor experiencia de usuario posible. La información de las cookies se almacena en tu navegador y realiza funciones tales como reconocerte cuando vuelves a nuestra web o ayudar a nuestro equipo a comprender qué secciones de la web encuentras más interesantes y útiles.
Fátima Al-Shahrour PhD, is head of the Bioinformatics Unit (https://bioinformatics.cnio.es/) at Spanish National Cancer Research Centre (CNIO). Her research focuses on applying and developing computational methods to precision medicine, for the interpretation of cancer genomes, drug repositioning and prediction of anticancer therapies. Her group is an active node of the Bioinformatics European network ELIXIR (ELIXIR-ES; https://inb-elixir.es/), leading the ELIXIR Cancer Data Focus Group to provide the framework and expertise for the systematic analysis and interpretation of cancer genomes. She is also co-director of Master in Bioinformatics Applied to Personalized Medicine and Health (ISCIII-ENS; BSC; CNIO; SEBIOT; https://masterbioinformatica.com/). As result of her scientific career, she has published more than 100 peer-reviewed articles in cancer genomics and bioinformatics focused on translational cancer research.
Fátima Al-Shahrour obtained her PhD from Universidad Autónoma de Madrid (UAM) in 2006. During her PhD (2002-2006) she worked at the Bioinformatics Unit at CNIO and Centro de Investigación Príncipe Felipe Valencia, CIPF (Valencia, Spain) under Dr. Joaquín Dopazo supervision. During this period, her research work dealt with the development of new Bioinformatics tools for microarray gene expression analysis, with a particular focus on computational methods for the functional interpretation of high-throughput experiments. In 2007, she was awarded with the José Castillejo mobility research grant from MICINN to join the Computational Biology group at Cancer Program under supervision of Prf. Dr. Jill P. Mesirov at Broad Institute of MIT and Harvard (Cambridge, USA). Her project was focusing mainly in the development of a computational methodology for identifying oncogenic transcriptional signatures. In 2008, she got a staff position at the Broad Institute as a Computational Biologist working at Dr. MD. Benjamin L. Ebert’s lab. During this period, her research was focused on the study the biology and treatment of cancer under a genomic perspective using hematopoiesis as a model system. After four years at the Broad Institute and BWH, in 2012 she joined the CNIO to lead the Translational Bioinformatics Unit (TBU) in the Clinical Research and Structural Biology and Biocomputing Programmes. Since 2017, she got a permanent position at CNIO and she leads the Bioinformatics Unit at CNIO